Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 19 April 2011
Vol. 4, Issue 169, p. ra24
[DOI: 10.1126/scisignal.2001309]
RESEARCH ARTICLES
Editor's Summary
Inhibition by Diversion
Signaling by receptors containing activating motifs called ITAMs stimulates pathways that lead to cellular activation. Paradoxically, ITAM receptors, including the immunoglobulin receptor FcαRI, can also inhibit signaling. Pfirsch-Maisonnas et al. found that the binding of low-affinity ligand resulted in the recruitment of FcαRI and the phosphatase SHP-1 to membrane lipid rafts. In a second step, ligation of the activating receptor FcRI resulted in its colocalization with FcαRI and SHP-1 in rafts, and the assembled proteins were internalized into intracellular structures called "inhibisomes," which prevented FcRI from activating its effectors. FcαRI also inhibited signaling by non–ITAM-containing receptors, which suggests that the recruitment of inhibitory ITAM receptors and SHP-1 to lipid rafts may constitute a general mechanism for the inhibition of activating receptors.
Citation: S. Pfirsch-Maisonnas, M. Aloulou, T. Xu, J. Claver, Y. Kanamaru, M. Tiwari, P. Launay, R. C. Monteiro, U. Blank, Inhibitory ITAM Signaling Traps Activating Receptors with the Phosphatase SHP-1 to Form Polarized "Inhibisome" Clusters. Sci. Signal.4, ra24 (2011).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Wei Wong (8 January 2013) Sci. Signal.6 (257), ec8.
[DOI: 10.1126/scisignal.2003941] |Abstract »
RESEARCH ARTICLES
Alexandra Mazharian, Ying-Jie Wang, Jun Mori, Danai Bem, Brenda Finney, Silke Heising, Paul Gissen, James G. White, Michael C. Berndt, Elizabeth E. Gardiner, Bernhard Nieswandt, Michael R. Douglas, Robert D. Campbell, Steve P. Watson, and Yotis A. Senis (30 October 2012) Sci. Signal.5 (248), ra78.
[DOI: 10.1126/scisignal.2002936] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
EDITORIAL GUIDES
Ernesto Andrianantoandro and John F. Foley (31 July 2012) Sci. Signal.5 (235), eg8.
[DOI: 10.1126/scisignal.2003412] |Abstract »|Full Text »|PDF »
PERSPECTIVES
Lionel B. Ivashkiv (19 April 2011) Sci. Signal.4 (169), pe20.
[DOI: 10.1126/scisignal.2001917] |Abstract »|Full Text »|PDF »
REVIEWS
Clare L. Abram and Clifford A. Lowell (13 March 2007) Sci. STKE2007 (377), re2.
[DOI: 10.1126/stke.3772007re2] |Gloss »|Abstract »|Full Text »|PDF »
REVIEWS
Jessica A. Hamerman and Lewis L. Lanier (31 January 2006) Sci. STKE2006 (320), re1.
[DOI: 10.1126/stke.3202006re1] |Gloss »|Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Specific inactivation of two immunomodulatory SIGLEC genes during human evolution.
X. Wang, N. Mitra, I. Secundino, K. Banda, P. Cruz, V. Padler-Karavani, A. Verhagen, C. Reid, M. Lari, E. Rizzi, et al. (2012)
PNAS
109, 9935-9940
|Abstract »|Full Text »|PDF »
ITAM-Coupled Receptors Inhibit IFNAR Signaling and Alter Macrophage Responses to TLR4 and Listeria monocytogenes.
L. Huynh, L. Wang, C. Shi, K.-H. Park-Min, and L. B. Ivashkiv (2012)
J. Immunol.
188, 3447-3457
|Abstract »|Full Text »|PDF »
IgG1 and IVIg induce inhibitory ITAM signaling through Fc{gamma}RIII controlling inflammatory responses.
M. Aloulou, S. Ben Mkaddem, M. Biarnes-Pelicot, T. Boussetta, H. Souchet, E. Rossato, M. Benhamou, B. Crestani, Z. Zhu, U. Blank, et al. (2012)
Blood
119, 3084-3096
|Abstract »|Full Text »|PDF »